Prevalence of osteopenia and osteoporosis in patients with moderate to severe asthma in Western Canada

Clinical and Investigative Medicine

Volumn 38, Issue 2, 2015, Pages E23-E30

  Li, Pen ^a   Ghazala, Laith ^a,b   Wright, Erin ^a   Beach, Jeremy ^a   Morrish, Donald ^a   Vethanayagam, Dilini ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Bredin Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT;

ALBERTA; ASTHMA; BONE DENSITY; BONE DISEASES, METABOLIC; COMPLICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RETROSPECTIVE STUDY;

ALBERTA; ANTI-ASTHMATIC AGENTS; ASTHMA; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 84929332478     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, et al. Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults. Can Respir J 2012 Mar-Apr;19(2):127-164.
2. Stein E, Shane E. Secondary osteoporosis. Endocrinol Metab Clin North Am 2003 Mar;32(1):115-34, vii.
3. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 1983 Aug 4;309(5):265-268.
4. Toogood JH. Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma. Allergy Asthma Clin Immunol 2005 Mar 15;1(1):28-33.
5. Tattersfield AE, Town GI, Johnell O, Picado C, Aubier M, Braillon P, et al. Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years. Thorax 2001 Apr;56(4):272-278.
6. Ward MJ. Inhaled corticosteroids--effect on bone? Respir Med 1993 Feb;87 Suppl A:33-5; discussion 35-6.
7. Wong CA, Walsh LJ, Smith CJ, Wisniewski AF, Lewis SA, Hubbard R, et al. Inhaled corticosteroid use and bone-mineral density in patients with asthma. The Lancet 2000 4/22;355(9213):1399-1403.
8. Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998 Mar;157(3 Pt 2):S1-53.
9. Goldstein MF, Fallon JJ,Jr, Harning R. Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest 1999 Dec;116(6):1733-1749.
10. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995 Nov;96(5 Pt 1):571-579.
11. Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group. N Engl J Med 2000 Oct 12;343(15):1054-1063.
12. Kelly HW, Sternberg AL, Lescher R, Fuhlbrigge AL, Williams P, Zeiger RS, et al. Effect of inhaled glucocorticoids in childhood on adult height. N Engl J Med 2012 Sep 6;367(10):904-912.
13. Hansen MA, Overgaard K, Riis BJ, Christiansen C. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ 1991 Oct 19;303(6808):961-964.
14. Gluck O, Colice G. Recognizing and treating glucocorticoidinduced osteoporosis in patients with pulmonary diseases. Chest 2004 May;125(5):1859-1876.
15. Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 2012 Sep;23(9):2239-2256.
16. World Health Organization. WHO scientific group on the assessment of osteoporosis at primary health care level. Summary Meeting Report 2004.
17. Dhanwal DK, Cooper C, Dennison EM. Geographic variation in osteoporotic hip fracture incidence: the growing importance of asian influences in coming decades. J Osteoporos 2010 Aug 2;2010:757102.
18. Barrera G, Bunout D, Gattas V, de la Maza MP, Leiva L, Hirsch S. A high body mass index protects against femoral neck osteoporosis in healthy elderly subjects. Nutrition 2004 Sep;20(9):769-771.
19. Volcheck GW. Does rhinitis lead to asthma? Evidence for the one-airway hypothesis. Postgrad Med 2004 May;115(5):65-68.
20. Bresciani M, Paradis L, Des Roches A, Vernhet H, Vachier I, Godard P, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 2001 Jan;107(1):73-80.
21. Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010 Nov 23;182(17):1864-1873.
22. Braun J. Epidemiology of corticosteroid-induced osteoporosis. Z Rheumatol 2001 Apr;60(2):107-110.
23. van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 2002 Oct;13(10):777-787.
24. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000 Jun;15(6):993-1000.
25. Hubbard R, Tattersfield A, Smith C, West J, Smeeth L, Fletcher A. Use of inhaled corticosteroids and the risk of fracture. Chest 2006 Oct;130(4):1082-1088.
26. Etminan M, Sadatsafavi M, Ganjizadeh Zavareh S, Takkouche B, FitzGerald JM. Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf 2008;31(5):409-414.
27. Wheelock C, Glass J, St Anna L. Clinical Inquiry. Do inhaled steroids reduce bone mineral density and increase fracture risk? J Fam Pract 2012 Aug;61(8):493-508.
28. ayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006 Mar;27(3):483-494.
29. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002 Nov 30;360(9347):1715-1721.
30. Mcivor RA, Pizzichini E, Turner MO, Hussack P, Hargreave FE, Sears MR. Potential masking effects of salmeterol on airway inflammation in asthma. Am J Respir Crit Care Med 1998 Sep;158(3):924-930.
31. Pakhale S, Sumner A, Coyle D, Vandemheen K, Aaron S. (Correcting) misdiagnoses of asthma: a cost effectiveness analysis. BMC Pulm Med 2011 May 23;11:27-2466-11-27.
32. Diette GB, Patino CM, Merriman B, Paulin L, Riekert K, Okelo S, et al. Patient factors that physicians use to assign asthma treatment. Arch Intern Med 2007 Jul 9;167(13):1360-1366.